
The Importance of Testing the Effectiveness of Deodorant Sprays against Bacteria That Cause Underarm Odor
The underarm is an area of the body that serves as a habitat for various microorganisms, including bacteria that play a role in the development of body odor. Warm, moist skin conditions, combined with the secretion of sweat, facilitate the activity of these microorganisms, leading to the production of volatile compounds that cause unpleasant odors.
To address this biological process, deodorant spray formulations are specifically designed with antibacterial agents to suppress the population of these microorganisms.
Table of Content:
- What Types of Bacteria Are Responsible for Producing Body Odor-Causing Compounds?
- The Relationship Between Deodorants Spray and Body Odor-Causing Bacteria
- How Is the Antimicrobial Effectiveness of Deodorant Spray Products Evaluated?
What Types of Bacteria Are Responsible for Producing Body Odor-Causing Compounds?
Body odor does not originate directly from the sweat produced by the body but is associated with the metabolic activities of microorganisms on the skin surface. Four major bacterial groups are involved in the production of body odor-causing compounds: Propionibacterium, Micrococcus, Staphylococcus, and Corynebacterium, with the latter two playing more dominant roles.
The Staphylococcus group produces volatile sulfur compounds that contribute to characteristic underarm odor. Several species involved include Staphylococcus hominis, Staphylococcus lugdunensis, and Staphylococcus haemolyticus, which are capable of converting sulfur-containing precursors into (S)-3-Methyl-3-Sulfanylhexan-1-ol (3M3SH), one of the compounds responsible for body odor with a strong characteristic smell.
The Corynebacterium group plays an important role in body odor formation through the metabolism of fatty acid precursors. The activity of these bacteria is associated with the production of 3-hydroxy-3-methyl-hexanoic acid (HMHA), a volatile fatty acid that contributes to the characteristic odor of the underarm area.
Other bacterial groups, such as Propionibacterium and Micrococcus, are also microorganisms associated with the production of body odor-causing compounds. However, the contribution of each bacterial group to odor intensity may vary depending on an individual’s skin microbiota characteristics and environmental conditions.
The presence of these bacteria is actually part of the normal human skin microbiota, and they are not necessarily harmful. However, the metabolic activities of certain species can increase the production of body odor-causing compounds, making the control of specific bacterial growth and activity one of the approaches used in deodorant spray product development.
The Relationship Between Deodorants Spray and Body Odor-Causing Bacteria
Deodorants spray are personal care products developed to control body odor, one of the ways being through the inhibition of bacteria that produce odor-causing compounds. Their mechanism of action primarily relies on antimicrobial active ingredients that can inhibit the growth of odor-causing microorganisms, also known as malodour-forming bacteria.
Several active ingredients commonly used in deodorant spray formulations include triclosan, propylene glycol, quaternary ammonium compounds, 2-ethylhexylglycerin, and ethyllauryl arginate hydroxychloride. These ingredients possess antimicrobial properties that help control bacterial growth on the skin surface, including members of the Staphylococcus and Corynebacterium groups.
Deodorant spray formulations may also contain fragrances and odor absorbers to improve body odor control. Fragrance ingredients such as limonene, linalool, and geraniol function to mask unpleasant odors, while ingredients such as zinc carbonate and talc can help reduce the presence of odor-causing compounds.
The use of deodorant spray and antiperspirants can influence the abundance and composition of bacterial communities living in the human armpit. However, the goal of developing antibacterial deodorants is not to eliminate all microorganisms on the skin, but rather to control bacteria that contribute to body odor formation without excessively disrupting the balance of the skin microbiota.
How Is the Antimicrobial Effectiveness of Deodorant Spray Products Evaluated?
Testing the antimicrobial effectiveness of deodorant spray products aims to determine the ability of their active ingredients or formulations to inhibit the growth of body odor-causing bacteria. Two commonly used in vitro methods for evaluating antibacterial activity are the Zone of Inhibition (ZOI) and Minimum Inhibitory Concentration (MIC) assays.
The Zone of Inhibition (ZOI) method can be performed using the Kirby-Bauer approach or the disk diffusion method to evaluate the ability of active ingredients to inhibit bacterial growth. Antibacterial activity is indicated by the formation of a clear zone around the disk containing the test substance, with its diameter subsequently measured in millimeters.
The Minimum Inhibitory Concentration (MIC) method is used to determine the lowest concentration of an active ingredient capable of visibly inhibiting bacterial growth. This test generally employs the broth dilution method using several concentrations of the test substance. Bacterial growth is then assessed based on the presence or absence of visible growth, indicated by changes in the turbidity of the medium.
Conduct your Deodorant Antibacterial Efficacy Testing at the IML Testing and Research
Need microbiological testing for your product? IML Testing and Research is ready to support your needs through microbiological testing services tailored to industrial and research requirements.
We utilize standardized microbiological analysis methods to measure your product’s zone of inhibition and kill rate against specific odor-causing bacteria, providing an objective Certificate of Analysis (CoA) to back your marketing claims. Consult Your Deodorant Efficacy Testing Now!
Author: Dherika
Editor: Lina
References
Callewaert, C., Hutapea, P., Van de Wiele, T., & Boon, N. (2014). Deodorants and antiperspirants affect the axillary bacterial community. Archives of Dermatological Research, 306, 701–710. https://doi.org/10.1007/s00403-014-1487-1.
Teerasumran, P., Velliou, E., Bai, S., & Cai, Q. (2023). Deodorants and antiperspirants: New trends in their active agents and testing methods. International Journal of Cosmetic Science, 45(4), 426–443. https://doi.org/10.1111/ics.12852.
